TREA

86370062 - BTG

Follow

Information

  • Trademark
  • 86370062
  • Serial Number
    86370062
  • Registration Number
    4962342
  • Filing Date
    August 18, 2014
    10 years ago
  • Registration Date
    May 24, 2016
    8 years ago
  • Transaction Date
    July 13, 2023
    a year ago
  • Status Date
    April 11, 2023
    a year ago
  • Published for Opposition Date
    July 07, 2015
    9 years ago
  • Location Date
    April 11, 2023
    a year ago
  • Status Code
    702
  • Current Location
    TMO LAW OFFICE 113
    Employee Name
    JACKSON, ELIZABETH FLE
  • Attorney Docket Number
    PLSS001.010T
    Attorney Name
    Jonathan A. Hyman
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
BTG
Case File Statements
  • GS0051: Pharmaceutical, medicinal and veterinary preparations and substances, namely, vaccines, antitoxic sera, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, inflammation, and autoimmune disease, pharmaceutical preparations for the treatment of envenomation by snakes, veterinary preparations for the treatment of envenomation by snakes, and dietetic foods adapted for medical use, namely, food supplements containing vitamins, minerals, trace elements, oils and fats, either apart or in combinations thereof for use in the treatment of cardiovascular issues, vascular issues or cancer, liquid medical sealants, and liquid adhesives for use in surgical and clinical procedure; pharmaceutical and medicinal preparations and substances, namely, vaccines and vaccine adjuvants, proteins, peptides, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances, and sepsis; drug delivery agents, namely, preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolisation; pharmaceutical preparations and substances for embolisation of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical and veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemico-pharmaceutical preparations for the treatment of envenomation by snakes; chemical preparations for medical and pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis and other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for the treatment of pre-eclampsia; chemical reagents for medical and veterinary therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis and other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; chemical preparations for medical and pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis and other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; transarterial chemoembolisation pharmaceutical preparations, vaccines and sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, therapeutic agents for delivery of radioactive materials to target sites within the body for the treatment of cancer; irradiated and radioactive microspheres used for in vivo therapeutic medical purposes, namely, beads in the nature of microscopic glass beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumors; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer and radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; beads, including microscopic radioactive beads featuring pharmaceutical preparations for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive pharmaceutical preparations and consisting of radioactive material for treatment of cancerous tumours; radioactive glass beads impregnated with pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams and for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, namely, for the treatment of oesophageal varices, hydroceles, in sterilisation treatment and for treatment of varicose veins, and arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy and for the treatment of autoimmune diseases; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents
  • GS0101: Surgical, medical and veterinary apparatus and instruments, namely, medical syringes, surgical and medical apparatus for producing and administering pharmaceutical foams, surgical and medical apparatus for producing foams for treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles, devices for intravenous administration of pharmaceutical foam, and diagnostic devices for grading the severity of venous conditions, snake envenomation and toxic drugs overdose; surgical, medical and veterinary apparatus and instruments, namely, medical devices for use in pulmonary and thoracic surgery and procedures, lung air trapping reduction coils, lung volume reduction devices, surgical implants comprising artificial material, surgical implants comprising artificial materials for restoring, maintaining and improving patient breathing and artificial surgical implants for restoring, maintaining and improving lung function, and catheters for deploying these; surgical, medical and veterinary apparatus and instruments, namely, medical device, apparatus and instruments for treating cancer; drug delivery embolisation apparatus, instruments and systems; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolization, namely, embolic devices for use in treating cancer and tumors, embolic devices for treating arteriovenous malformations (AVMs) of the body, and embolic devices for use in treating tumors; drug delivery embolisation systems; drug delivery apparatus and instruments namely, a drug delivery system comprised of injection syringes and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; medical apparatus and instruments for embolization, namely, medical devices in the nature of embolic microspheres for embolization; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; beads, namely, microscopic radioactive glass beads administered surgically for treatment of cancerous tumours; radioactive beads, namely, radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; medical devices in the nature of drug delivery systems which use ultrasound to enhance drug delivery and medically activate drugs; catheters for delivery of drugs and fluids sold together as a unit with controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus sold together as a unit with controllers and power units therefor; needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology and proctology; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology and proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices and hycroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles; devices for assessing the physical characteristics of such foams, namely, medical diagnostic apparatus for analyzing the efficacy of sclerotherapy foams for medical purposes; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of sclerosing foam in the human body for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical diagnostic apparatus for diagnosing all the above medical conditions, namely, varicose veins, arterio-venous malformations, oesophageal varices, spider veins hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; compression bandages; component parts and fittings for all of the aforesaid goods; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes, namely, implantable radiation therapy devices consisting of radioactive beads in the nature of microscopic radioactive beads for treatment of cancerous tumours; implantable radiation therapy devices consisting of radioactive beads and a bioabsorbable carrier assembly, namely, beads in the nature of microscopic radioactive beads for treatment of cancerous tumours and beads in the nature of radioactive microscopic glass beads for treatment of cancerous tumours; radioactive glass beads, namely, implantable radiation therapy devices consisting of radioactive beads and a bioabsorbable carrier assembly and implantable radiation therapy devices consisting of radioactive beads; radioactive glass beads, namely, implantable radiation therapy devices consisting of radioactive glass beads administered for treatment of cancerous tumours
Case File Event Statements
  • 7/13/2023 - a year ago
    61 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/13/2023 - a year ago
    60 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/13/2023 - a year ago
    59 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/11/2023 - a year ago
    58 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 4/11/2023 - a year ago
    57 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A
  • 4/7/2023 - a year ago
    56 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 3/16/2023 - a year ago
    55 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 3/16/2023 - a year ago
    54 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/16/2023 - a year ago
    53 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 3/16/2023 - a year ago
    52 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/16/2023 - a year ago
    51 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 9/28/2022 - 2 years ago
    50 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 4/12/2022 - 2 years ago
    49 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/12/2022 - 2 years ago
    48 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/12/2022 - 2 years ago
    47 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 4/12/2022 - 2 years ago
    46 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/12/2022 - 2 years ago
    45 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/12/2022 - 2 years ago
    44 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 8/30/2021 - 3 years ago
    43 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 8/30/2021 - 3 years ago
    42 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/30/2021 - 3 years ago
    41 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 8/30/2021 - 3 years ago
    40 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 8/30/2021 - 3 years ago
    39 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 5/24/2021 - 3 years ago
    38 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 4/22/2021 - 3 years ago
    37 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 8/29/2020 - 4 years ago
    36 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 8/29/2020 - 4 years ago
    35 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/29/2020 - 4 years ago
    34 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Type: EWOR
  • 8/29/2020 - 4 years ago
    33 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 8/29/2020 - 4 years ago
    32 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 8/29/2020 - 4 years ago
    31 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 5/24/2016 - 8 years ago
    30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/14/2016 - 8 years ago
    29 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 2/22/2016 - 8 years ago
    28 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 4/3/2016 - 8 years ago
    27 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 2/22/2016 - 8 years ago
    26 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR
  • 9/1/2015 - 9 years ago
    25 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/7/2015 - 9 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/7/2015 - 9 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/17/2015 - 9 years ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/1/2015 - 9 years ago
    21 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 6/1/2015 - 9 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/28/2015 - 9 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/27/2015 - 9 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/27/2015 - 9 years ago
    17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/13/2015 - 9 years ago
    16 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 4/13/2015 - 9 years ago
    15 - PRIORITY ACTION E-MAILED Type: GPRA
  • 4/13/2015 - 9 years ago
    14 - PRIORITY ACTION WRITTEN Type: CPRA
  • 3/21/2015 - 9 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/20/2015 - 9 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/20/2015 - 9 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/21/2014 - 10 years ago
    10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/21/2014 - 10 years ago
    9 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/21/2014 - 10 years ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/14/2014 - 10 years ago
    7 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/29/2014 - 10 years ago
    6 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/29/2014 - 10 years ago
    5 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/29/2014 - 10 years ago
    4 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/22/2014 - 10 years ago
    3 - ASSIGNED TO LIE Type: ALIE
  • 8/21/2014 - 10 years ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 8/21/2014 - 10 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP